Aeterna Therapeutics

About Aeterna Therapeutics

The startup develops proprietary monoclonal antibodies targeting oncology and metabolic disorders, utilizing advanced antibody engineering techniques to enhance specificity and efficacy. By addressing the need for effective treatments in these complex diseases, the company aims to improve patient outcomes and reduce healthcare costs.

What does Aeterna Therapeutics do?

The startup develops proprietary monoclonal antibodies targeting oncology and metabolic disorders, utilizing advanced antibody engineering techniques to enhance specificity and efficacy. By addressing the need for effective treatments in these complex diseases, the company aims to improve patient outcomes and reduce healthcare costs.

Where is Aeterna Therapeutics located?

Aeterna Therapeutics is based in San Diego, United States.

When was Aeterna Therapeutics founded?

Aeterna Therapeutics was founded in 2024.

Location
San Diego, United States
Founded
2024
Employees
5 employees
Looking for specific startups?
Try our free semantic startup search

Aeterna Therapeutics

Score: 54/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

The startup develops proprietary monoclonal antibodies targeting oncology and metabolic disorders, utilizing advanced antibody engineering techniques to enhance specificity and efficacy. By addressing the need for effective treatments in these complex diseases, the company aims to improve patient outcomes and reduce healthcare costs.

aeternatherapeutics.com50+
Founded 2024 – San Diego, United States

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (5+)

Tracey Mullen

Entrepreneur / Biotech Executive

Aeterna Therapeutics | StartupSeeker